Stocks and Investing Stocks and Investing
Wed, April 19, 2023

Josh Schimmer Initiated (BBIO) at Buy and Held Target at $40 on, Apr 19th, 2023


Published on 2024-10-28 02:51:55 - WOPRAI, Josh Schimmer
  Print publication without navigation


Josh Schimmer of Evercore ISI Group, Initiated "BridgeBio Pharma, Inc." (BBIO) at Buy and Held Target at $40 on, Apr 19th, 2023.

Josh has made no other calls on BBIO in the last 4 months.



There are 5 other peers that have a rating on BBIO. Out of the 5 peers that are also analyzing BBIO, 0 agree with Josh's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Josh


  • Mani Foroohar of "SVB Securities" Maintained at Buy with Increased Target to $27 on, Thursday, April 13th, 2023
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $28 on, Tuesday, March 7th, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Tuesday, March 7th, 2023
  • Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $29 on, Tuesday, March 7th, 2023
  • Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Monday, February 6th, 2023

Contributing Sources